Randomized phase IIb study of Cabazitaxel in metastatic Colorectal Cancer resistant to standard treatment

Trial Profile

Randomized phase IIb study of Cabazitaxel in metastatic Colorectal Cancer resistant to standard treatment

Discontinued
Phase of Trial: Phase II

Latest Information Update: 12 Aug 2014

At a glance

  • Drugs Cabazitaxel (Primary)
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Acronyms COMETA
  • Most Recent Events

    • 03 Mar 2014 As per the EudraCT record, the status changed from recruiting to discontinued.
    • 06 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top